Articles

A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilities

Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
Haematologica Early view Jul 25, 2024 https://doi.org/10.3324/haematol.2023.284761